Cefprozil treatment of persistent and recurrent acute otitis media

Pediatric Infectious Disease Journal

Volumn 16, Issue 5, 1997, Pages 471-478

  Pichichero, Michael E ^a   Mclinn, Samuel ^b   Aronovitz, Gerson ^c   Fiddes, Robert ^d   Blumer, Jeffrey ^e   Nelson, Kathleen ^f   Dashefsky, Barry ^g  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Scottsdale Healthcar   (United States)

^c EMORY UNIVERSITY   (United States)

^d SCRI Inc   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Acute otitis media; bacterial resistance; cefprozil; Streptococcus pneumoniae

Indexed keywords

CEFPROZIL;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; DOSE RESPONSE; DRUG RESPONSE; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; OTITIS MEDIA; PERSISTENT INFECTION; PRIORITY JOURNAL; RECURRENT INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, ORAL; CEPHALOSPORINS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; OTITIS MEDIA WITH EFFUSION; PROSPECTIVE STUDIES; RECURRENCE;

EID: 0030990747     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199705000-00003     Document Type: Article

References (36)

1. Berman S. Otitis media in children. N Engl J Med 1995;332: 1560-5.
2. Teele DW, Klein JO, Rosner B and the Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989;160:83-93.
3. Alho OP, Koivu M, Sorri M, Rantakallio P. Risk factors for recurrent acute otitis media and respiratory infection in infancy. Int J Pediatr Otorhinolaryngol 1990;19:151-61.
4. Rodriguez WJ, Schwartz RH, Thorne MM. Increasing incidence of penicillin-and ampicillin-resistant middle ear pathogens. Pediatr Infect Dis J 1995;14:1075-8.
5. Pichichero ME, Pichichero CL. Persistent acute otitis media: I. Causative pathogens. Pediatr Infect Dis J 1995;14:178-83.
6. Nelson CT, Mason EO, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J 1994;13:585-9.
7. Bradley JS, Kaplan SL, Klugman KP, Leggiadro RJ. Consensus: management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr Infect Dis J 1995;14:1037-41.
8. Mason EO, Lamberth L, Lichenstein R, Kaplan SL. Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in vitro susceptibility to selected oral antibiotics. J Antimicrob Chemother 1995;36:1043-8.
9. Mason EO, Kaplan SL. Penicillin-resistant pneumococci in the United States. Pediatr Infect Dis J 1995;14:1017-8.
10. Boken DJ, Chartrand SA, Moland ES, Goering RV. Colonization with penicillin-nonsusceptible Streptococcus pneumoniae in urban and rural child-care centers. Pediatr Infect Dis J 1996;15:667-72.
11. Stutman HR, Arguedas AG. Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media. Clin Infect Dis 1992;14(Suppl 2):S204-8.
12. Fung-Tomc JC, Huczko E, Stickle T, et al. Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides. Antimicrob Agents Chemother 1995;39: 533-8.
13. Shyu WC, Haddad J, Reilly J, et al. Penetration of cefprozil into middle ear fluid of patients with otitis media. Antimicrob Agents Chemother 1994;38:2210-12.
14. McLinn SE, Moskal M, Goldfarb J, et al. Comparison of cefuroxime axetil and amoxicillin-clavulanate suspensions in treatment of acute otitis media with effusion in children. Antimicrob Agents Chemother 1994;38:315-8.
15. Asmar BI, Dajani AS, DelBeccaro MA, Mendelman PM and the Otitis Media Study Group. Comparison of cefpodoxime axetil and cefixime in the treatment of acute otitis media in infants and children. Pediatrics 1994;94:847-51.
16. Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82.
17. Pichichero ME, Pichichero CL. Persistent acute otitis media: II. Antimicrobial treatment. Pediatr Infect Dis J 1995;14: 183-8.
18. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995;14:751-9.
19. Hoberman A, Paradise JL, Block S, Burch DJ, Jacobs MR, Balanescu MI. Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility. Pediatr Infect Dis J 1996;15:955-62.
20. Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis J 1996;15:980-5.
21. Gehanno P, Lenoir G, Berche P. In vivo correlates for Streptococcus pneumoniae, penicillin resistance in acute otitis media. Antimicrob Agents Chemother 1995;39:271-2.
22. Thornsberry C, Burton P, Vanderhoof B, et al. Regional differences in beta-lactamase and ampicillin and cefprozil resistance in Haemophilus influenzae in the United States. Adv Ther 1996;13:301-11.
23. Marchant CD, Shurin PA, Turczyk VA, et al. Course and outcome of otitis media in early infancy: a prospective study. J Pediatr 1984;104:826-31.
24. Arguedas AG, Zaleska M, Stutman HR, Blumer JL, Hains CS. Comparative trial of cefprozil vs. amoxicillin/clavulanate potassium in the treatment of children with acute otitis media with effusion. Pediatr Infect Dis J 1991;10:375-80.
25. Aronovitz GH, Doyle CA, Durham SJ, et al. Cefprozil vs. amoxicillin/clavulanate in the treatment of acute otitis media. Infect Med 1992;9(Suppl C):19-31.
26. Brook I, Yocum P. Bacteriology and beta-lactamase activity in ear aspirates of acute otitis media that failed amoxicillin therapy. Pediatr Infect Dis J 1995;14:805-7.
27. Howie VM, Dillard R, Lawrence B. In vivo sensitivity test in otitis media: efficacy of antibiotics. Pediatrics 1985;75:8-13.
28. Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J 1993;12:973-5.
29. Klein JO, Bluestone CD, Howie VM. Discussion. Clin Infect Dis 1992;14(Suppl 2):S209-11.
30. Howie VM. Otitis media. Clin Infect Dis 1994;19:823-33.
31. Reilly JS, Doyle WJ, Cantekin EI, et al. Treatment of ampicillin-resistant acute otitis media in the chinchilla. Arch Otolaryngol 1983;10:533-5.
32. Liden M, Foldstrom A, Thore M. Treatment of early recurrences of acute purulent otitis media: value of myringotomy. Acta Otolaryngol (Stockh) 1988;106:441-7.
33. Engelhard D, Strauss N, Jorczak-Sarni L, Cohen D, Sacks TG, Shapiro M. Randomized study of myringotomy, amoxicillin/clavulanate, or both for acute otitis media in infants. Lancet 1989;2:141-3.
34. Bluestone CD, Cantekin EI. Design factors in the characterization and identification of otitis media and certain related conditions. Ann Otol Rhinol Laryngol 1979;88(Suppl 60):13-27.
35. Qvarnberg Y, Palva T. Active and conservative treatment of acute otitis media. Ann Otol Rhinol Laryngol 1980;89(Suppl 68):269-70.
36. Doern GV. Does there exist a rational, objective in vitro basis for the management of selected infections of the respiratory tract? Infect Dis Clin Pract 1994;3:75-80.